[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
张雪菲, 张帅, 于雁. 凝血指标异常与非小细胞肺癌转移及预后的关系[J]. 现代肿瘤医学, 2016, 24(13): 2070-2072.
|
[3]
|
张学振, 陈国荣, 李君艳. 食管鳞癌患者凝血指标与临床病理特征的关系[J]. 山东医药, 2017, 57(22): 15-18.
|
[4]
|
朱小双, 孙轶华. 血小板在肿瘤转移中的研究进展[J]. 中国实验诊断学, 2020, 24(3): 522-525.
|
[5]
|
董超男, 翟文萍, 王雪野. 血小板介导肿瘤细胞生长和转移的机制研究进展[J]. 医学综述, 2020, 26(4): 695-699.
|
[6]
|
Liu, Y.H., Liu, X.B., Xu, L., et al. (2018) Magnetic Resonance Imaging Evaluation of Treatment Efficacy and Prognosis for brain Metastases in Lung Cancer Patients after Radiotherapy: A Preliminary Study. Thoracic Cancer, 9, 865-873.
https://doi.org/10.1111/1759-7714.12763
|
[7]
|
李延青. 炎症性肠病癌变的内镜筛查及化学预防[J]. 中国实用内科杂志, 2018, 38(9): 780-783.
|
[8]
|
黄远玲, 李纯团, 王少雄, 郑艳, 朱雄鹏. 胃癌患者凝血功能、D二聚体、血小板计数的变化与肿瘤临床特征的关系[J]. 血栓与止血学, 2019, 25(6): 906-908+912.
|
[9]
|
申太峰, 王悦, 杨帆. 子宫颈浸润癌与血小板增多的临床分析[J]. 中国妇产科临床杂志, 2014, 15(4): 295-297.
|
[10]
|
Burger, J.A. and Kipps, T.J. (2006) CXCR4: A Key Receptor in the Crosstalk between Tumor Cells and Their Microenvironment. Blood, 107, 1761-1767. https://doi.org/10.1182/blood-2005-08-3182
|
[11]
|
Nagata, S. and Fukunaga, R. (1993) Granulocyte Colony-Stimulating Factor Receptor and Its Related Receptors. Growth Factors, 8, 99-107. https://doi.org/10.3109/08977199309046930
|
[12]
|
任莲萍,沈晨辉. 肿瘤相关性血管疾病[J]. 国外医学肿瘤学分册,1998, 25(2): 78-79.
|
[13]
|
孙旺远, 高蔚, 翁婷, 王丽芳, 沈威, 施斌. 肺癌患者血小板参数的临床意义[J]. 中国校医, 2017, 31(5): 365-367.
|
[14]
|
张永瑞, 白泽坤, 翟丽. 肿瘤患者血小板参数显示不全的原因分析[J]. 国际检验医学杂志, 2018, 39(20): 2531-2534.
|
[15]
|
Franco, A.T., Corken, A. and Ware, J. (2015) Platelets at the Interface of Thrombosis, Inflammation, and Cancer. Blood, 126, 582-588. https://doi.org/10.1182/blood-2014-08-531582
|
[16]
|
朱建华. 肺癌患者化疗前后凝血、纤溶功能相关指标和血小板计数变化分析[J]. 中国基层医药, 2016, 23(19): 3014-3017.
|
[17]
|
Perisanidis, C., Psyrri, A., Cohen, E.E., Engelmann, J., Heinze, G., Perisanidis, B., Stift, A., Filipits, M., Kornek, G. and Nkenke, E. (2015) Prognostic Role of Pretreatment Plasma Fibrinogen in Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Treatmentreviews, 41, 960-970.
https://doi.org/10.1016/j.ctrv.2015.10.002
|
[18]
|
Lee, S.E., Lee, J.H., Ryu, K.W., Nam, B.-H., Cho, S.J., Lee, J.Y., Kim, C.G., Choi, I.J., Kook, M.-C., Park, S.R. and Kim, Y.-W. (2012) Preoperative Plasma Fibrinogen Level Is a Useful Predictor of Adjacent Organ Involvement in Patients with Advanced Gastric Cancer. Journal of Gastric Cancer, 12, 81-87.
https://doi.org/10.5230/jgc.2012.12.2.81
|
[19]
|
Mark, J.J., McGonigle, N.C., McAnespie, M., Cran, G.W. and Graham, A.N. (2006) Plasma Fibrinogen and Serum C-Reactive Protein Are Associated with Non-Small Cell Lung Cancer. Lung Cancer, 53, 97-101.
https://doi.org/10.1016/j.lungcan.2006.03.012
|
[20]
|
Zhao, J., Zhao, M.F., Jin, B., Yu, P., Hu, X.J., Teng, Y., Zhang, J.D., Luo, Y., Zhang, L.J., Zheng, S., Zhou, Q.Y., Li, H.M., Liu, Y.P. and Qu, X.J. (2012) Tumor Response and Survival in Patients with Advanced Non-Small-Cell lung Cancer: The Predictive Value of Chemotherapy-Induced Changes in Fibrinogen. BMC Cancer, 12, Article No. 330.
https://doi.org/10.1186/1471-2407-12-330
|
[21]
|
王卉媛. 凝血常规检查在肺癌患者中的应用价值分析[J]. 中国医药指南, 2019, 17(32): 18-19.
|
[22]
|
李敏, 綦晓龙, 唐国富, 李厚泽. D-二聚体、纤维蛋白原及其降解产物对胃癌诊断价值分析[J]. 实用医院临床杂志, 2019, 16(2): 101-103.
|
[23]
|
史青苗, 薛晨, 何玉婷, 任志刚, 余祖江. 肝细胞肝癌患者血浆纤维蛋白原、D-二聚体改变的临床意义[J]. 河南医学研究, 2018, 27(23): 4232-4234.
|
[24]
|
Wen, J.H., Yang, Y.N., Ye, F., Huang, X.J., Li, S.J., Wang, Q. and Xie, X.M. (2015) The Preoperative Plasma Fibrinogen Level Is an Independent Prognostic Factor for Overall Survival of Breast Cancer Patients Who Underwent Surgical Treatment. The Breast, 24, 745-750. https://doi.org/10.1016/j.breast.2015.09.007
|
[25]
|
Sabine, K.-P., Uwe, L., Stojakovic, T., Pichler, M., Gerger, A., Kapp, K.S. and Langsenlehner, T. (2015) An Elevated Preoperative Plasma Fibrinogen Level Is Associated with Poor Disease-Specific and Overall Survival in Breast Cancer Patients. Breast, 24, 667-672. https://doi.org/10.1016/j.breast.2015.08.003
|
[26]
|
魏炎, 李锴男, 毕经旺. 消化系统肿瘤中纤维蛋白原及D-二聚体的表达及临床价值[J]. 生物技术通讯, 2016, 27(4): 542-544.
|
[27]
|
陈辰, 李利亚. 术前血小板、血浆纤维蛋白原及D-二聚体水平与小细胞肺癌预后的相关性分析[J]. 现代肿瘤医学, 2019, 27(7): 1148-1153.
|
[28]
|
王文闻, 肖燕, 王琦. 血浆D-二聚体在胰腺癌患者中的临床意义[J]. 中国肿瘤外科杂志, 2020, 12(3): 219-222.
|
[29]
|
林颖欣, 庞丹梅, 胡倩, 段海波, 陈秀云. D-二聚体水平与转移性乳腺癌化疗效果及预后的关系[J]. 广东医科大学学报, 2019, 37(6): 700-703.
|
[30]
|
Hara, K., Aoyama, T., Hayashi, T., Nakazono, M., Nagasawa, S., Shimoda, Y., Kumazu, Y., Numata, M., Yamada, T., Tamagawa, H., Shiozawa, M., Morinaga, S., Yukawa, N., Rino, Y., Masuda, M., Ogata, T. and Oshima, T. (2020) Postoperative D-Dimer Elevation Affects Tumor Recurrence and the Long-Term Survival in Gastric Cancer Patients Who Undergo Gastrectomy. International Journal of Clinical Oncology, 25, 584-594.
https://doi.org/10.1007/s10147-019-01603-x
|
[31]
|
赵乐, 杨国栋, 常永超. D-二聚体联合CA19-9、SCC对食管癌的诊断价值[J]. 实验与检验医学, 2019, 37(5): 882-884.
|
[32]
|
Liang, Y.X., He, D.L., Wu, L.L., Ding, X.W., Wang, X.N., Wang, B.G., Zhang, R.P. and Liang, H. (2018) Elevated Preoperative Plasma D-Dimer Dose Not Adversely Affect Survival of Gastric Cancer after Gastrectomy with Curative Intent: A Propensity Score Analysis. Chinese Journal of Cancer Research, 30, 254-262.
https://doi.org/10.21147/j.issn.1000-9604.2018.02.08
|